Publication Beamlines Strategic Pillar
J·塞奥内苏亚雷斯; J·阿尼多富尔盖拉; J·弗兰森; R·M·哈勒特; M·帕斯夸尔加西亚 et al. (2021). Combination of LIF inhibitors and PD-1 axis inhibitors for the treatment of cancer. Patent Number: CN112585164A.
J·赛瓦内苏阿雷斯; J·阿尼多福尔盖拉; P·A·吉布林; P·E·拜利斯; J·弗兰松 et al. (2021). Method for quantifying LIF and uses thereof. Patent Number: CN112654395A.
Kelsey Sivick Gauthier; John Lippincott; Nigel Pelham Clinton Walker; Xiaoning Zhao (2023). Anti-tigit antibodies. Patent Number: CO2022017348A2.
Kelsey Sivick Gauthier; John Lippincott; Nigel Pelham Clinton Walker; Xiaoning Zhao (2024). Antibodies to tigit. Patent Number: PH12022553257A1.
Kelsey Sivick GAUTHIER; John Lippincott; Nigel Pelham Clinton Walker; Xiaoning Zhao (2022). Antibodies to TIGIT. Patent Number: AU2021284273A1.
Kelsey Sivick Gauthier; Nigel Pelham Clinton Walker; Xiaoning Zhao; John Lippincott (2023). Anti-tigit antibodies. Patent Number: CL2022003397A1.
Kelsey Sivick Gauthier; Nigel Pelham Clinton Walker; Xiaoning Zhao; John Lippincott (2022). ANTI-TIGIT ANTIBODIES. Patent Number: AR122493A1.
Kelsey Sivick Gauthier; Nigel Pelham Clinton Walker; Xiaoning Zhao; John Lippincott (2023). ANTI-TIGIT ANTIBODIES. Patent Number: PE20231078A1.
Kelsey Sivick GAUTHIER; Nigel Pelham Clinton Walker; Xiaoning Zhao; John Lippincott (2021). Antibodies to tigit. Patent Number: WO2021247591A1.
Kelsey Sivick GAUTHIER; Nigel Pelham Clinton Walker; Xiaoning Zhao; John Lippincott (2023). Antibodies to tigit. Patent Number: EP4157875A1.
Kelsey Sivick GAUTHIER; Nigel Pelham Clinton Walker; Xiaoning ZHAO; John Lippincott (2023). Antibodies to TIGIT. Patent Number: US11820824B2.
Kelsey Sivick GAUTHIER; Nigel Pelham Clinton Walker; Xiaoning ZHAO; John Lippincott (2025). Antibodies to TIGIT. Patent Number: US12415854B2.
Kin S. Yang; Hang Chu; Solomon H. Reisberg; Wai Yan Choy; Brian P. Bestvater et al. (2025). Reversible lysine covalent modifiers of cdk2 and uses thereof. Patent Number: US20250289789A1.
Kin S. YANG; Hang CHU; Solomon H. REISBERG; Wai Yan CHOY; Brian P. BESTVATER et al. (2025). Reversible lysine covalent modifiers of cdk2 and uses thereof. Patent Number: WO2025090658A2.
Kodandaram Pillarisetti; Eric Thomas Baldwin; Gordon D Powers; Cardoso Rosa Maria Fernandes; Ricardo Attar et al. (2026). Anti-BCMA antibodies, bispecific antigen-binding molecules that bind to BCMA and CD3, and their uses. Patent Number: AR134557A2.